Jeffrey Toobin of New Yorker is suspended after Zoom incident
In a statement, the magazine said it was investigating a matter involving the author and CNN legal analyst. — New York Times: Top Stories
Great f.y.i. Get hooked here!
In a statement, the magazine said it was investigating a matter involving the author and CNN legal analyst. — New York Times: Top Stories
The researchers are seeking up to 90 healthy volunteers between the ages of 18 and 30. — FOX News
CHATHAM, N.J.–(BUSINESS WIRE)–Retail investing hit several new highs for account openings, number of trades, and volume traded in Q3 amid the ongoing global economic uncertainty due to the pandemic, according to new data released today by DriveWealth, a leader in global digital
Italy once again ramped up coronavirus restrictions in a bid to avoid a new nationwide lockdown, as parts of the United Kingdom have already reinstated lockdowns similar to those seen in March, and Poland converted a major stadium into a field hospital
NEW YORK & CRANBURY, N.J.–(BUSINESS WIRE)–Onyx Enterprises Int’l, Corp. (“Onyx”), owner and operator of a leading digital commerce platform for the automotive market, “CARiD.com,” which has entered into a definitive business combination agreement with Legacy Acquisition Corp. (NYSE: “LGC”) (“Legacy”), a publicly-traded
Alexander Zverev ended his 17-month wait for a title by drawing on the pain of his U.S. Open final defeat to beat Felix Auger-Aliassime tennis 6-3, 6-3 and win the Cologne Indoors on Sunday. — FOX News
Sunday’s election is seen as a referendum on the 14-year political project of Evo Morales, a towering figure in Bolivian politics who lifted many out of poverty but whose policies and tone divided the country. — New York Times: Top Stories
Dallas police officers praised for their quick response to a car submerged in a local lake earlier this week, said they were just doing their jobs. — FOX News
OPTIMIZE Pivotal Study 1 Year Outcomes Announced at TCT Connect NEW PROVIDENCE, N.J.–(BUSINESS WIRE)–The Svelte® Drug-Eluting Stent (DES) achieved 1.5% clinically-driven Target Lesion Revascularization (TLR) at 1 year, the lowest ever reported in an Investigational Device Exemption (IDE) clinical study. Primary and